‘Genetic doppelgangers:’ Emory research provides insight into two neurological puzzles

An international team led by Emory scientists has gained insight into the pathological mechanisms behind two devastating neurodegenerative diseases. The scientists compared the most common inherited form of amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) with a rarer disease called spinocerebellar ataxia type 36 (SCA 36). Both of the diseases are caused by abnormally expanded and strikingly similar DNA repeats. However, ALS progresses quickly, typically killing patients within a year or two, while the disease Read more

Emory launches study on COVID-19 immune responses

Emory University researchers are taking part in a multi-site study across the United States to track the immune responses of people hospitalized with COVID-19 that will help inform how the disease progresses and potentially identify new ways to treat it.  The study is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The study – called Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) – launched Friday. Read more

Marcus Lab researchers make key cancer discovery

A new discovery by Emory researchers in certain lung cancer patients could help improve patient outcomes before the cancer metastasizes. The researchers in the renowned Marcus Laboratory identified that highly invasive leader cells have a specific cluster of mutations that are also found in non-small cell lung cancer patients. Leader cells play a dominant role in tumor progression, and the researchers discovered that patients with the mutations experienced poorer survival rates. The findings mark the first Read more

Joseph Allen

The Bayh-Dole Act: 30 Years of Innovation

At Emory’s recent Fourth Celebration of Technology and Innovation, faculty researchers and entrepreneurs were recognized for outstanding accomplishments in developing promising technologies that are moving from the laboratory to the marketplace.

Keynote speaker for the annual event was Joseph Allen, a key staff member in helping Senator Birch Bayh (D-IN) secure passage of the Bayh-Dole Act 30 years ago, opening up collaborations between research universities and U.S. industry.

Todd Sherer, executive director of Emory’s Technology Transfer Office, described Emory’s robust product pipeline, which includes products at all stages of development and regulatory approval. The pipeline helps ensure multiple missions of driving academic discoveries, advancing commercially protected technologies, and providing substantial public benefit.

Read more

Posted on by admin in Uncategorized Leave a comment